News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

News|Videos|August 31, 2023

Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD

Sponsored by: Ironshore Pharmaceuticals

Episodes in this series

EP. 1 Chapter 1. History of Stimulants in ADHD

EP. 1 Chapter 1. History of Stimulants in ADHD

EP. 2 Chapter 2. Guidance and Recommendations for the use of Stimulants in Adults With ADHD

EP. 2 Chapter 2. Guidance and Recommendations for the use of Stimulants in Adults With ADHD

EP. 3 Chapter 3. Pharmacokinetic Profiles of Long-Acting Stimulants

EP. 3 Chapter 3. Pharmacokinetic Profiles of Long-Acting Stimulants

EP. 4 Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD

EP. 4 Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD

EP. 5 Chapter 5. Adult Perspectives on ADHD Medications

EP. 5 Chapter 5. Adult Perspectives on ADHD Medications

EP. 6 Chapter 6. Optimizing the Duration of Effect with Stimulant Medications

EP. 6 Chapter 6. Optimizing the Duration of Effect with Stimulant Medications

EP. 7 Chapter 7. Stimulant Prescribing Practices for Patients With ADHD

EP. 7 Chapter 7. Stimulant Prescribing Practices for Patients With ADHD

EP. 8 Chapter 8. Managing Patient Expectations During Treatment for ADHD

EP. 8 Chapter 8. Managing Patient Expectations During Treatment for ADHD

EP. 9 Appropriate Use of Stimulant Medications in Adults With ADHD

EP. 9 Appropriate Use of Stimulant Medications in Adults With ADHD

IP001858 08/23

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

depression

Navigating the Complexity of Major Depressive Disorder

ByRoger S. McIntyre, MD, FRCPC

March 18th 2024

Chapter 8. Managing Patient Expectations During Treatment for ADHD

By

August 31st 2023

Chapter 7. Stimulant Prescribing Practices for Patients With ADHD

By

August 31st 2023

Chapter 6. Optimizing the Duration of Effect with Stimulant Medications

By

August 31st 2023

Chapter 5. Adult Perspectives on ADHD Medications

By

August 31st 2023

Latest CME

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Changes in Gut Microbiome May Be Connected to Alzheimer Disease and Mild Cognitive Impairment

Is Preparing for Death and Dying the Most Important Life Task After Turning 80?

Presenting Our February 2026 Theme: Bipolar Disorder

Artificial Intelligence, Job Loss, and the Psychiatric Significance of Work

Updating the DSM: Reviewing the New APA DSM Recommendations